6
Publications
2.3K
Citations
6
H-Index
2003
Active since
Affiliations
Johnny E. Kopinja is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and immunology.
Top concepts
MedicinePharmacologyImmunologyTumor BiologyCell DeathCell BiologyInflammationImmunotherapyCancer BiologyCell Signaling
Publications per year
2003–2022
6
6
Douglas A. Rubinson, Christopher P. Dillon, Adam V. Kwiatkowski et al. · Nature Genetics · 2003 · 1.5K citations
Developmental Biology, Rna Interference, Lentivirus-based System +9
An orally available non-nucleotide STING agonist with antitumor activity
Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit
Johnny E. Kopinja, Raquel Sevilla, Diane Levitan et al. · Scientific Reports · 2017 · 51 citations · Full text
An inhibitor of Janus kinase 2 prevents polycythemia in mice
Anjili Mathur, Jan-Rung Mo, Manfred Kraus et al. · Biochemical Pharmacology · 2009 · 19 citations
Rows per page
1–5 of 6